Every emphasised callout and every pulled quote, extracted slide-by-slide. Search by keyword, filter by slide type or by source.
"Management goes to great lengths to convince investors that they’re transparent and respond to investor feedback on more disclosure. However, their statements about being “open to the conversation” seem hallow and their attempts to justify failing to do so (“candidly, I’m not quite sure how much more detail we could provide“) suggests they’re unlikely to increase transparency meaningfully."
"How can TurboTax disclosed Paying ARPR only increase 7% from 2020 to 2023 when (1) Online and Live average list prices rose 10% and 9%, (2) Intuit launched the highest ASP Full Service offering in 2021, and (3) we estimate that higher list ASP Live as a percent of total paying returns grew from 7% to 18% over the same period. We believe this suggests weak price realization."
"It sounds as if IPX's potential customer funnel has been dramatically reduced. After indicating that 200 potential customers had signed NDAs in October 2024, IPX said customer activities accelerated by June 2024. IPX now says it counts ~100 active potential customer programs which suggests that at least 50% of the potential customer pool may have already declined interest."
"The previous study covered MAUDE data through 2021. Our review from 2018 to the present shows Aquablation has resulted in 24 deaths since FDA approval. Moreover, FDA adverse event data suggests Procept's transfer of manufacturing operations to a new location in Q3 2023 resulted in above-trend equipment malfunctions, suggesting poor execution at patients' expense."
"Procept’s “utilization” definition is handpieces “purchased”, not handpieces “used”. If handpieces “purchased” overstates known US procedures (as the Company’s proxy disclosure suggests), and if rising DSOs are indicative of hospitals ordering more handpieces than they need, then not only is Procept’s “utilization” metric overstated, it might even be meaningless."
"Sell-side promoters are divided on Zebra, and there is even one analyst with an underweight opinion and market perform rating and a $290 per share price target. We believe that even that is overly optimistic because analysts fail to conduct a rigorous forensic review of Zebra's recent acquisitions and financial reporting which suggests more issues lie ahead."
"While DuPont may portray Trian’s involvement as intrusive, history suggests the result is enhanced performance and long-lasting, collaborative relationships with management and other board members; perhaps best evidenced by Trian’s continuing relationships with Bill Johnson, Arthur Winkleblack and Dennis Reilley (Heinz) and Dennis Kass (Legg Mason)"
"While DuPont may portray Trian’s involvement as intrusive, history suggests the result is enhanced performance and long-lasting, collaborative relationships with management and other board members; perhaps best evidenced by Trian’s continuing relationships with Bill Johnson, Arthur Winkleblack and Dennis Reilley (Heinz) and Dennis Kass (Legg Mason)"
"While DuPont may portray Trian’s involvement as intrusive, history suggests the result is enhanced performance and long-lasting, collaborative relationships with management and other board members; perhaps best evidenced by Trian’s continuing relationships with Bill Johnson, Arthur Winkleblack and Dennis Reilley (Heinz) and Dennis Kass (Legg Mason)"
"While DuPont may portray Trian’s involvement as intrusive, history suggests the result is enhanced performance and long-lasting, collaborative relationships with management and other board members; perhaps best evidenced by Trian’s continuing relationships with Bill Johnson, Arthur Winkleblack and Dennis Reilley (Heinz) and Dennis Kass (Legg Mason)"
"While DuPont may portray Trian’s involvement as intrusive, history suggests the result is enhanced performance and long-lasting, collaborative relationships with management and other board members; perhaps best evidenced by Trian’s continuing relationships with Bill Johnson, Arthur Winkleblack and Dennis Reilley (Heinz) and Dennis Kass (Legg Mason)"
"While DuPont may portray Trian’s involvement as intrusive, history suggests the result is enhanced performance and long-lasting, collaborative relationships with management and other board members; perhaps best evidenced by Trian’s continuing relationships with Bill Johnson, Arthur Winkleblack and Dennis Reilley (Heinz) and Dennis Kass (Legg Mason)"
"Assuming Mettler made the $242m of permanent capital injection into the HK entity, our working theory is that it would have experienced a capital shortfall and needed to raise more debt. However, the fact that it did not suggests it maybe shuffling the money around internally, potentially to show auditors in China evidence of accumulated profits."
"pitolisant is a “potent inhibitor of CYP2D6 and hERG”; “our laboratory findings suggest that CYP2D6 inhibition...would likely be important hurdles for this novel compound”; and that “in vitro profiling in our laboratory (and others) suggests that BF2.639 [pitolisant] has both a CYP2D6 liability...and potent hERG channel K+ blockade.”"
"We find no evidence that Kornit is hiring in Japan or has opened a Japanese office. It relies on two distributors in the country, and has only one regional manager we could identify, who has been with Kornit just one year. This suggests that Kornit is not prepared to grow with Amazon in Japan and may have already lost the business."
"Using the Wayback Machine, we find troubles with key performance indicators reported by Burgiss. Burgiss consistently referenced serving over 1,000 clients since 2019. However, now MSCI says it has approximately 1,000 clients. This suggests that the Company's client count has been stagnant to potentially down over four years."
"Spruce Point fact-checked C3's claim from a May 23, 2018 press release announcing a partnership with Intel. We observe that on the same day C3 announced the alliance, Intel also issued a press release about enterprise AI, without referencing C3.(1) A review of Intel's website suggests limited evidence of a deep partnership."
"GILEAD scientist with five years of experience with BLI, across several large pharma/biotech companies, is one of the most experienced users and has declined to recommend purchase at Gilead; suggests BLI's pipeline has dwindled in last 4-6 months; "limited market" with competing technologies about to take share."
"Ares Capital marked Soil Safe's equity at zero and booked a $13m “net realized gain”. This suggests the deal was close to the value of the debt's fair value. The double digit interest rates paid by Soil Safe at a time of ultra low borrowing costs illustrate that Soil Safe was a deeply distressed company."
"By closely examining the composition of WD-40's inventory accounts, we observe that Finished Goods make up an increasing percentage of the overall balance, and more than prior to entering the last crisis. In our opinion, this suggests that inventory is building up and not selling-through to customers."
"Spruce Point has discovered that BR was recently advertising to hire a new Chief Accounting Officer. Yet, what happened to David J. Lisa? His LinkedIn profile suggests he's still with BR.(1) If there has been a transition in accounting leadership, why did BR not file an 8-K to disclose his departure?"
"Spruce Point believes Ballard investors should be cautioned by its history of partnership failures in China, notably Azure in 2013-15. Our on the ground due diligence strongly suggests this time around with Synergy/Broad Ocean will result in disappointment and a significant stock price correction."
"Spruce Point observes two conflicting stories around the departure of Mr. Glover from Blucora. The public press release says he resigned, which suggests his departure was voluntary. However, the proxy statement later described him as a terminated executive and having received a severance payment."
"Despite the seemingly sound logic of single embryo transfer, research suggests that PGNY’s claims that this practice will ensure the reduced incidence (and, most importantly, resultant costs) of pre-term births are questionable, or at least provide an incomplete picture of the aggregate outcomes."
"We believe Limbach significantly overstates its free cash flow, which in turn inflates its reported Adj. EBITDA-to-FCF conversion rate. While the Company claims an 80% conversion rate over the past six years, our Spruce Point-adjusted FCF analysis suggests the true figure may be less than 60%."
"Note that the announcement states that these farms were designed for beef ranching, which strongly suggests that the farms were never intended to be operated by Huishan, and that the plan all along had been to use Huishan investors’ money to build beef cattle ranches for Chairman Yang."
"The deterioration of Skechers' cash flow margins since 2018, coupled with a history of mismatch between its CFO and net income (before non-controlling interest) and thus highly suspect earnings quality, suggests that something is fundamentally wrong with the Company's financial model."
"Since Soleno appears to have forgotten to change the fasting glucose graph from the original dataset, we can calculate associated HbA1c values - which suggests to us that the new HbA1c numbers are simply made up to fit a misleading narrative that entry ITT were already prediabetic."
"Petitioner is aware of three reports in recent weeks of young patients hospitalized for potential heart failure shortly after starting VYKAT XR. In the last few days, new information has emerged which suggests the total number of hospitalizations may be seven patients or higher."
"The evidence suggests that Axon has aggressively recognized revenues. These aggressive accounting choices were known to be blessed by Arthur Andersen, the now defunct auditor, that famously signed-off on Enron’s financial statements and was charged with obstruction of justice."
"Is nearly all of HIMS’ mental health physician organization operating without a valid corporate registration? Our research of PC laws in several states, including California, suggests that a current registration is required for healthcare-related entities to operate legally."
"Industry sources suggest that MGPI's key customers are Diageo, High West, Sagamore Spirit and Templeton Rye. Each of these customers (as well as Terresentia) are adding their own production capacity and storage which suggests they may no longer need to do business with MGPI."
"Based on stock sale transactions and IPO filings, it appears as though both Matrix and Purple Sky owned the entirety of Momo’s A-1 preferred shares. This is irreconcilable and suggests that one or both vehicles may have been used to enrich Momo insiders prior to the IPO."
"While the overall number of WFG agents continues to grow, multi-ticket agents, or agents who write more than 1 policy in a year, actually fell sequentially in Q3'24. This suggests productive agents may be leaving WFG, potentially as a result of GFI's recruiting efforts."
"This suggests that Aegon's senior leadership is not only aware of Guillermo's ongoing involvement with the organization, despite his past conduct, but also allows him to hold a role of such significance that he is permitted to present openly at WFG's annual convention."
"Aside from the overall amount of revenue and deferred revenue being implausible - we estimate $6.3MM of deferred revenue per Allonnia employee - the timing of when Ginkgo booked these amounts from Allonnia strains credibility and suggests they are clearly fictitious."
"Our analysis suggests that a sale to one of the many well-capitalized buyers likely to engage in a process would deliver a meaningful premium relative to where Forward Air's shares have traded over the last 12 months, while eliminating further risk for shareholders."
"From Company disclosures regarding the sales histories and pro-forma revenue contributions of recently-acquired businesses, our analysis suggests that Hill-Rom’s acquisitions consistently show top-line contraction immediately following their acquisition by Hill-Rom."
"But a detailed examination of the trial design and the results suggests that Convergent will end up at the same impasse as AtriCure's prior minimally invasive endeavors – an overly complicated procedure offering few incremental benefits for the incremental cost."
"The letter’s tone suggests alarm, noting ~108,000 MDR’s (medical device reports) received by the FDA including ~78k injuries, 29k malfunctions, and 500 deaths – and concludes by urging providers and patients “to report any adverse events...with SCS” to the FDA."
"Total receivables have ballooned 456% in the same period that revenues have grown 99%. This suggests that Axon has booked revenues, generally associated with the weapon (and body cam), in advance of its ability to collect on these sales in a timely fashion."
"The fact that Bob Chapek was abruptly fired five months after the Board unanimously agreed to extend his contract by three years suggests the Board lacks a robust CEO succession process and completely misread the state of Disney’s & Bob Chapek’s performance"
"Spruce Point finds clear that Saputo is struggling in Europe, and recently made modifications to its competition discussion that suggests a loss of share. We observe that the percentage of retail sales are in decline, and that EBITDA margins are declining."
"Thus, our estimation using a corrected comparator suggests that the PhenoTest is faster by about 16h to deliver AST results, because it does skip the step of sub-cultures. Therefore, the time advantage is only 40% and not more than 75%, as claimed by AXDX."
"Our rigorous forensic analysis suggests it may be outright impossible for Amcor to meet lofty analyst expectations, with revenues already vanishing, deal costs higher than planned, and critical maintenance and growth capital expenditures being delayed."
"Ballard is currently trading near an all-time high valuation on the belief its China growth story will materialize and profits will finally appear. Our on the ground research in China suggests a different base case outcome of financial disappointment."
"Our research suggests that Kratos is a tiny player in the field of unmanned systems, with approximately 1% share of industry revenues and contract awards as a percentage of the DoD budget for drone procurement, research, development and construction."
"We are struck by the disconnect between Amdocs' European footprint and the value of its European assets, which suggests that it has made sizeable investments in software, computer equipment, etc. in locations in which it has little physical presence."
"The offer suggests not only desperation but an attempt to mislead investors by essentially fabricating sales of the “new” A300, which is simply the A150 with a different light source and a new name in an attempt to cover up a defective light source."
"The offer suggests not only desperation but an attempt to mislead investors by essentially fabricating sales of the “new” A300, which is simply the A150 with a different light source and a new name in an attempt to cover up a defective light source."
"The offer suggests not only desperation but an attempt to mislead investors by essentially fabricating sales of the “new” A300, which is simply the A150 with a different light source and a new name in an attempt to cover up a defective light source."
"The offer suggests not only desperation but an attempt to mislead investors by essentially fabricating sales of the “new” A300, which is simply the A150 with a different light source and a new name in an attempt to cover up a defective light source."
"DuPont’s inability to deliver on Kullman’s agenda suggests that she needs more help to overcome the 100+ years of history and the inertia that comes with that; Trian can be Kullman’s best ally. For shareowners, Trian’s impact is already very clear."
"DuPont’s inability to deliver on Kullman’s agenda suggests that she needs more help to overcome the 100+ years of history and the inertia that comes with that; Trian can be Kullman’s best ally. For shareowners, Trian’s impact is already very clear."
"Limbach's declining position on the Engineering News-Record's (“ENR”) Top Mechanical Contractors list, from 9th in 2018 to 14th in 2024, underscores intensifying competition in the sector and suggests the Company has lost market share over time."
"AMR's Investor Presentation claimed 14.2 million tons of production in 2020. Another source suggests 14.37 million tons of coal produced that was sold in 2020. However, it's possible this includes tons produced in 2019 that were sold in 2020."
"VW feedback suggests QS is feeding them scraps of cherry-picked information, which fuels skepticism among VW’s engineers – test cells are behaving in an instable manner; internal commentary that test results they see are not representative."
"The strong correlation and recent spike of both Helly Hansen Canada Revenue and CTC's Intersegment Revenue suggests Canadian Tire is pushing inventory to CTC retail stores in order to show strong growth in its struggling Helly Hansen brand"
"All in all, this suggests that if METC were to mine $37 billion worth of REEs from their Brook Mine, we estimate they would lose ~$88 billion in the process, which would forever cement METC as the most capital destructive mine in history."
"The contrived phrasing suggests that Quantumscape is trying to mislead investors into thinking that this is the first time they’ve made multi-layer cells, when all they’re saying is that this is the first time they’re talking about it."